Beyond the standard of care: the role of cytopathology in molecular testing of cancer
Cancer Treat Res
.
2014:160:273-82.
doi: 10.1007/978-3-642-38850-7_11.
Author
Peter Kulesza
1
Affiliation
1
Department of Pathology, Northwestern University, 251 E. Huron St. Galter Pavilion 7-132E, Chicago, IL, 60611, USA,
[email protected]
.
PMID:
24092374
DOI:
10.1007/978-3-642-38850-7_11
No abstract available
Publication types
Review
MeSH terms
Biomarkers, Tumor
Drug Resistance, Neoplasm
Humans
Neoplasms / diagnosis
Neoplasms / drug therapy
Neoplasms / pathology*
Substances
Biomarkers, Tumor